C
Cuimin Ding
Researcher at Hebei Medical University
Publications - 26
Citations - 571
Cuimin Ding is an academic researcher from Hebei Medical University. The author has contributed to research in topics: Lung cancer & Medicine. The author has an hindex of 8, co-authored 17 publications receiving 330 citations.
Papers
More filters
Journal ArticleDOI
First-line icotinib versus cisplatin/pemetrexed plus pemetrexed maintenance therapy for patients with advanced EGFR mutation-positive lung adenocarcinoma (CONVINCE): a phase 3, open-label, randomized study.
Yuankai K. Shi,Lvhua Wang,Baohui Han,Wei Li,P. Yu,Y. Liu,Cuimin Ding,X. Song,Z. Y. Ma,X. L. Ren,J. F. Feng,Helong Zhang,Gong Yan Chen,Xiaohong Han,Ning Wu,C. Yao,Yinglin Song,Shu Cai Zhang,Wei Song,Xiaoqing Liu,S. J. Zhao,Y. C. Lin,X. Q. Ye,Kai Li,Y. Q. Shu,L. M. Ding,F. L. Tan,Y. Sun +27 more
TL;DR: First-line icotinib significantly improves PFS of advanced lung adenocarcinoma patients with EGFR mutation with a tolerable and manageable safety profile and should be considered as a first-line treatment for this patient population.
Journal ArticleDOI
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial
Zhijie Wang,Ying Cheng,Tongtong An,Hongjun Gao,Kai Wang,Qing Zhou,Yanping Hu,Yong Song,Cuimin Ding,Feng Peng,Li Liang,Yi Hu,Cheng Huang,Caicun Zhou,Yuankai Shi,Li Zhang,Xin Ye,Meizhuo Zhang,Shao-Kun Chuai,Guanshan Zhu,Hu Jin,Yi-Long Wu,Jie Wang +22 more
TL;DR: A prospective clinical trial to assess ctDNA-based EGFR mutation detection as a selection criterion for patients with lung adenocarcinoma receiving gefitinib as first-line treatment and found that EGFR mutations detected in ct DNA is an effective method to identify patients who might benefit from first- line gefITinib treatment.
Journal ArticleDOI
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial.
Shun Lu,Lin Wu,Hong Jian,Ying Chen,Qing Wang,Jian Fang,Ziping Wang,Yanping Hu,Meili Sun,L.N. Han,Liyun Miao,Cuimin Ding,Jiuwei Cui,Baolan Li,Yueyin Pan,Xing-Ya Li,Feng Ye,Anwen Liu,Ke Wang,Shundong Cang,Huilin Zhou,Xing-Yu Sun,David Ferry,Yong Lin,Shuyan Wang,Wen Xiao Zhang,Chengli Zhang +26 more
TL;DR: In this article , the authors evaluated the efficacy and safety of sintilimab with or without IBI305 plus pemetrexed and cisplatin, compared with pemetroxed and cisplatin alone for the treatment of patients with locally advanced or metastatic EGFR-mutated non-small-cell lung cancer (NSCLC) who had disease progression after receiving EGFR tyrosine-kinase inhibitor therapy.
Journal ArticleDOI
China Experts Consensus on the Diagnosis and Treatment of Brain Metastases of Lung Cancer (2017 version)
Yuankai Shi,Yan Sun,Jinming Yu,Cuimin Ding,Zhiyong Ma,Ziping Wang,Dong Wang,Zheng Wang,Mengzhao Wang,Yan Wang,You Lu,Bin Ai,Jifeng Feng,Yunpeng Liu,Xiaoqing Liu,Jiwei Liu,Gang Wu,Baolin Qu,Xueji Li,E. Li,Wei Li,Yong Song,Gongyan Chen,Zhengtang Chen,Jun Chen,Ping Yu,Ning Wu,Milu Wu,Wenhua Xiao,Jianping Xiao,Li Zhang,Yang Zhang,Yiping Zhang,Shucai Zhang,Xia Song,Rongcheng Luo,Caicun Zhou,Zongmei Zhou,Qiong Zhao,Chengping Hu,Yi Hu,Ligong Nie,Qisen Guo,Jianhua Chang,Cheng Huang,Baohui Han,Xiaohong Han,Gong Li,Yu Huang,Youwu Shi +49 more
TL;DR: China Experts Consensus on the Diagnosis and Treatment of Brain Metastases of Lung Cancer (2017 version)
Journal ArticleDOI
OA04.03 A Randomized Phase 3 Study of Camrelizumab plus Chemotherapy as 1st Line Therapy for Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
C. Zhou,Gongyan Chen,Yunchao Huang,Jiaojiao Zhou,L. Lin,Jifeng Feng,Zujian Wang,Y. Shu,J. Shi,Yi Hu,Q. Wang,Y. Cheng,J. C. Chen,Xiaoyan Lin,Yuelong Wang,Jian-An Huang,Jiuwei Cui,L. Cao,Yunpeng Liu,Y. Zhang,Y. Pan,J. B. Zhao,Lei Wang,J. Chang,Quan Chen,Xiubao Ren,W. Zhang,Yi-Zhong Fan,Z. He,J. Fang,Kangsheng Gu,X. Dong,F. Jin,H. Gao,Guangpeng An,Cuimin Ding,Xuejun Jiang,Jianping Xiong,Xiangdong Zhou,Shouyang Hu,Ping Lu,A. Liu,Shu-liang Guo,C. Zhu,Beili Gao,Y. B. Chen,Chengping Hu,Jian Zhang,Helong Zhang,H. Zhao,Yanshuang Zhou,Y. Tai +51 more